chrisvoncsefalvay/vaers-outcomes huggingface dataset:
(History obtained from EMR and patient's parents. VAERS report filed by the local Health Dept.) The patient received their 12 month MMR (right thigh), Hep. A (right thigh), Varicella (left thigh), and PCV-13 (left thigh) on 6/1/2016. The patient experienced low grade fever and was irritable for the next five days. On 6/6/2016 a raised, erythematous lesion began around the injection site on the left thigh. On 6/7/2017 the rash was also note on the back of the patient's neck and where the patient's diaper contacted the skin. The patient's mother describes the rash as, "red, pimply, like chicken pox, like roseola rash." By 6/8/2016 the rash had spread to the trunk, legs and arms. By 6/9/2016 the rash had spread to the face. The patient's mother states that she believes the rash was itchy or irritating the patient because that patient responded to topical creams. The patient's rash had cleared by 6/25/2016 with the exception of some continued, mild erythema at the injection site. The patient is also now afebrile and has normal behavior. The patient was not treated with anything but diaper rash creams and topical antibiotic and moisturizing creams.
p/receiving a dose of Typhoid vax, pt devel cellulitis @ site of inject;
Mild Headache - 12 hours   Fever followed by a hot flash - 12 hours followed by a 15 minute hot flash   Joint Pain - 12 hours   Fatigue - 24 hours
Pericarditis, treated with standard dose colchicine (0.6 mg 2x day), ibuprofen (600 mg 2x day) , and pantoprazole (1x day to prevent ulcers from ibuprofen). Pain resolved over the course of about 2 months.
Urticarial reaction localized to deltoid spreading to upper  bicep started  3 days after injection , slowly worsening still on day 14
Pt woke up on day 2 following second vaccine dose and had itchy face, scalp, and swollen lower eyelids.
ACUTE DVT, UNSPECIFIED VEIN ACUTE DVT OF RIGHT POPLITEAL VEIN ACUTE PULMONARY EMBOLISM
elevated temperature, aches and pains, change in taste of food and drinks. Sore throat, fluid in both ears. Heaviness in chest. Bruising at Injection site. muscle and joint pain. Stomach pain and upset, decreased appetite . feeling tired and weak with chills.
Took first Vivotif 6/28/05, #2 06/30/05pm, Insomnia, nausea. Dillusional thinking, unaware of surroundings. To hospital ER, diagnosis manic episode, to treatment facility 10 days. Lithium, Zyprexia, Lamictal.
both cheeks were very rosy red; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot EL3246) via an unspecified route of administration on 14Jan2021 (in the morning) at a single dose as COVID-vaccine, she got it as a protection to her because she's elderly with underlying conditions. Medical history was not reported. Concomitant medications included unspecified five prescriptions which she has been taking for a long time (nothing new). She has had no reaction to medications. Her diet was her normal diet. The patient experienced both cheeks were very rosy red on 14Jan2021 21:30. She wanted to know if experiencing very rosy red cheeks, on both sides, after receiving the Covid vaccine was a normal side effect. She received the first dose of the COVID Pfizer vaccine yesterday morning on 14Jan2021, everything was fine (good) at 7:30 p.m. Then at 9:30 p.m., while she was brushing her teeth, she noticed that both cheeks were very rosy red (her cheeks were rosy red). This morning, her cheeks appeared to be skin tone (skin looked normal). It was gone now; both cheeks were her normal skin tone and everything looked normal now. She didn't eat anything unusual the day of the vaccine. She was wondering if she should go back on 15Feb2021. She was going to ask her doctor and was going to notify her primary care doctor as well if she experiences any redness today or tomorrow. Investigation assessment was noted as no. The outcome of the event was recovered on 15Jan2021.
Woke with a stomach, my joints hurt, headache and extremely tired. Symptoms lasted 24 hours except for the joints hurting and that lasted for four days.
no other AE; pharmacist called to report a temperature excursion that occured on 13/AUG/2021, 14/AUG/2021 and 15/AUG/2021, PEDVAX HIB was given on 18/AUG/2021; This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions, allergies and concomitant medications were not reported.   On 18-AUG-2021, the patient was vaccinated with improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) 1 dose time, lot # T024020, expiration date reported as 13-MAR-2023, but upon internal validation it was established as 31-MAR-2023 for prophylaxis (exact doses, dose #, route of administration and anatomical location were not reported).  The temperature excursions occurred on 13-AUG-2021, 14-AUG-2021 and 15-AUG-2021. The temperature was as following: 10, 9.4 and 9.5 degrees Celsius for cumulative time 1 hour 27 min. There were no previous excursions reported. It was unknown if the digital data logger was involved. No signs or symptoms reported.
MMR II VACCINE WAS ADMINISTERED ON 09/13/2022 AT 4:30PM. PT. WAS HEALTHY WITHOUT SYMPTOMS OF ILLNESS WHEN THE VACCINE WAS ADMINISTERED. ON 09/14/2022 AT 8:00AM PT. WAS AWAKEN FOR SCHOOL, WHEN I NOTICED SWELLING AROUND AND BETWEEN HER EYES, SWELLING OF THE CHEEKS AND SWELLING UNDER CHIN. SHE WAS ALSO UNABLE TO BREATHE THROUGH HER NOSE DUE TO NASAL CONGESTION AND MUCUS BUILD UP IN THE NASAL CAVITY. SHE ALSO HAD A FEVER OF 102.8 AND HER LIPS WERE DRY WITH SIGNS OF DEHYDRATION. I THEN ADMINISTERED ACETAMINOPHEN (10ML) TO COMBAT THE FEVER AND ANTIHISTAMINE (10ML) TO COMBAT ALL ALLERGY SYMPTOMS. SOON AFTER SHE WAS SEE AT URGENTCARE ABOUT 8:35 AM ON 09/14/2022. I WAS INSTRUCTED TO TAKE HER HOME AND CONTINUE HOME TRAETMENT AND WATCH HER SYMPTOMS FOR THE NEXT 5 DAYS. SHE HAD A CONTINUED FEVER AND SWELLING 9/15/2022 AND  9/16/2022. AND I CONTINUES TRAETMENTS AS REQUIRED. TODAY 9/17/2022 SHE HAS A LOWER TEMPT OF 97.0 AND THE SWELLING IN GOING DOWN.
symptoms consistent with anaphylaxis; This is a literature report. A health-care system experience. The full publication has been requested. This author reported different events for five patients. This is the fifth of five reports.  A subject of unspecified age and gender received bnt162b2 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. The medical history and concomitant medications were not reported. The subject experienced symptoms consistent with anaphylaxis on an unspecified date with outcome of unknown. The subject underwent lab tests and procedures which included allergy test with unknown results.  Background: Adverse reactions, including anaphylaxis, to messenger RNA coronavirus disease 2019 (COVID-19) vaccines rarely occur. Because of the need to administer a timely second dose in subjects who reported a reaction to their first dose, a panel of health-care professionals developed a safe triage of the employees and health care providers at a large health-care system to consider administration of future dosing. Methods: There were 28,544 providers who received their first dose of COVID-19 vaccines between December 15, 2020, and March 8, 2021. The providers self-reported adverse reactions to a centralized COVID-19 AGENCY center. The AGENCY screened and collected information on the quality of reaction, symptoms, and timing of the onset of the reaction. Results: Of 1253 calls to the agency, 113 were identified as requiring consideration by a panel of three certified allergists for future dosing or formal in-person assessment. Of the 113 cases, 94 (83.2%) were recommended to get their second dose. Eighty of 94 received their second planned dose without a severe or immediate reaction. Of the 14 of 113 identified as needing further evaluation, 6 were evaluated by a physician and subsequently received their second dose without a serious adverse reaction. Eight of 14 did not receive their second dose. Only 5 of the 113 cases reported reactions (4.4%) were recommended to not take the second dose: 3 (2.6%) because of symptoms consistent with anaphylaxis, and 2 because of neurologic complications (seizure, stroke). Conclusion: The panel demonstrated that, by consideration of reaction history alone, the providers could be appropriately triaged to receive scheduled second dosing of COVID-19 vaccines without delays for in-person evaluation and allergy testing.; Sender's Comments: A contributory role of BNT162B2 in triggering the onset of Anaphylaxis cannot be fully excluded, considering the temporal relationship and known adverse event profile of the suspect vaccine,Linked Report(s) : US-PFIZER INC-202101300055 Same article/drug/event; Different patient
fever/steady fever/Caller says his fever got as high as 101.5 degrees Fahrenheit; This is a spontaneous report from a contactable Other Health Professional (patient) from a Pfizer-sponsored program IBCC (Inbound Call Center for HCPs). An 82 years old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot EL0140) via an unspecified route of administration on 21Dec2020 at single dose in left arm for COVID-19 immunisation. Medical history and concomitant medications were none. Warm transfer in regards to the COVID vaccine which he received Monday morning. Agent reports caller said since then he has had a steady fever and has questions in regards to side effects. As for Height: Caller says he is shrinking, he is about 5 feet 9 inches tall. No further details provided about shrinking. Caller clarifies his doctor title and says that he is not a physician or medical doctor, he has a PhD in psychology. Caller says he doesn't have a prescribing provider, he got the vaccine at a retirement home called (facility name and location). Caller says that his fever started the day he got the shot. He says he got the shot that morning, clarified to being about noon, and had a fever that evening. Caller clarifies that he takes Advil, not Aspirin for his fever. He says when he takes the Advil it goes away, it gets rid of it, but when the Advil wears off the fever comes back again. He says he has no idea what side effects of this drug are, so he thought he would give a call because others were worried about it and pressured him to ask. Caller says the only information he has is the card, the COVID-19 Vaccine Record Card, which says Pfizer, then below it EL0140, which could be either 0 or letter O, probably 0. He says it has the date 21Dec2020 on it from when he got it and he got it in his left arm, it was his first injection of it, he has another to come. Caller says his fever got as high as 101.5 degrees Fahrenheit on 22Dec2020, and he also has a fever right now. Therapeutic measures were taken as a result of fever and included treatment with Advil. Outcome of event was not recovered.
Approx. 4:55pm pt. came back to flu shot area and asked what was in shot. Stated hands were swelling and itching, SOB, chest tightness, rash around waist band.
I have had to go to the ER twice now once 01/9/22 and 01/11/2022 with rapid heart race and chest pains, sweating
Pt complained of sharp, left sided chest pain.  presented to ED for evaluation .  found to have elevated troponins, CRP,  with normal EKG and echo. Dx with myopericardititis. Treated with colchicine.
Case number PHEH2012US023531 is a spontaneous report initially received from a nurse on 27 Nov 2012 with a follow-up received on 03 Dec 2012: This case refers to a 48-year-old female patient. She was vaccinated only with the MenCYW-135 component of MENVEO (batch number: X12013) intramuscularly on 21 Nov 2012. No adverse event was reported following this drug administration error. She was vaccinated with another complete dose of MENVEO on an unspecified date. No other information was available. Follow-up received from the nurse on 03 Dec 2012: Updated re-vaccination information with MENVEO.
The patient reported that the day after she had the flu injection she had a small bump on the left arm the size of a mosquito bite at the site of injection. She stated the area got larger and she went to a doctor on 9/30/15 who prescribed antibiotics. The site started itching and was still visible on 10/1/15 so she went to the State Wellness Center. The doctor there prescribed some topical cream and had drawn blood for labs.
This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Sore arm), MYALGIA (achy), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. Concurrent medical conditions included Thalassemia minor and Mitral valve disease NOS (mitral valve problem).  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm), MYALGIA (achy), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea). At the time of the report, PAIN IN EXTREMITY (Sore arm), MYALGIA (achy), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown. Concomitant medication and treatment information were not reported. Due to existing medical history the patient does not want to take the second dose. Action taken with mRNA-1273 in response to the event was Not Applicable.
patient presented to hospital for heart palpitation in SVT 180-190's. Patient had no light headness or dizziness. Patient was cardioverted and improved. Discharged 2/18. Per EAU, hospitalizations are to be reported irrespective of attribution to the vaccine
High fever; Trouble catching my breath; Shaking; Body aches; This is a spontaneous report from a contactable consumer (patient).   A 30-year-old male patient received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6203) via an unspecified route of administration, administered in arm left on 24Feb2021 18:00 (at the age of 30 years old) as dose 1, single for COVID-19 immunisation. Medical history included high blood pressure. Concomitant medications included alprazolam (XANAX) and blood pressure (as reported). Allergies to medications, food, or other products was reported to none. On 26Feb2021 19:30, the patient experienced high fever, trouble catching breath, shaking, and body aches. There was no other vaccine in four weeks. No COVID prior vaccination and not COVID tested post vaccination. There was no treatment for the events. The outcome of the event was recovering.   No follow up attempts are possible. No further information is expected.
pt recv vax; devel red & swollen arm; employee felt there was a problem w/ the lot;
Sulfuric smells have a metallic scent; odors that are normally recognizable are not.
got shingles p/varivax vax 6NOV97;shingles 5MAR98;
Patient received vaccines:  Anthrax (6th of the series), Typhoid Vi, and small pox all on the 28 th of March 2007.  Vigorous inflammatory response at site of small pox inoculation reported.  On 8 April, the patient developed chest pains with ST elevations.  Cardiac cath on 10 April showed normal coronaries.  Cardiac enzymes mildly positive.  Clinical presentation consistent with acute myopericarditis.  Initial echo showed mild hypokinesis of the distal lateral and inferior walls.  Repeat echo showed normal LV systolic function and wall motion; only trace pericardial effusion noted.
DTaP from Aventis lot U1258ba exp 5/5 and IPV from Aventis lot x0772 exp 7/6 given into left arm. 24 hour arm red, swollen and warm to touch. 6" area affected.
Headache treated with glass water and multivitamin takenabout 8 hours after injection.  Next morning: General body aches, no treatment. Pain at injection site, no treatment. Fatigue, bed rest.
it's toxic; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of TOXICITY TO VARIOUS AGENTS (it's toxic) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TOXICITY TO VARIOUS AGENTS (it's toxic). At the time of the report, TOXICITY TO VARIOUS AGENTS (it's toxic) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided.  Treatment information was not reported.  Other countries stopped giving the Moderna and Pfizer's vaccine because it's toxic.   This case was linked to MOD21-131922 (E2B Linked Report).; Sender's Comments:  MOD21-131922:
Chills, body aches, lymph node swelling, headache, severe fatigue, purple bruise, swallowing issue
Pain, swelling, redness at site; on 6/2/2017 doctor's visit, she was informed that the site looked worse than it should.
4/4 2021 - Red raised Rash at the injection site about the size of a quarter 4/5 2021 _ Itchy raised rash, sore to the touch about the size of a dollar piece 4/6 2021 - Itchy raised, hard and hot.  sore to the touch about 3" round  4/7 2021 - Itchy raised, hard, sore to the touch about 3 1/2" round  Called Dr. Was told to take Benadryl, Tylenol, compress If no improvement the next bay then I had to come in to the office.  I started to see some improvement-not as red. over the next two day it continued to itch less,  redness was fading, still itchy and hard.  By the 11th they swelling was down to the size of a quarter and redness was gone but still itchy.  4/18 it was about the size of a pea still a little itchy but doesn't hurt and no redness.  However,  on 4/13 around 6:30 pm I had to be rushed to the hospital couldn't breath, vision and speech was declining . was admitted for blood clot that cut the oxygen to brain causing a mini stroke
I started having severe pain in my right arm and my lower right arm became numb and now my right index finger has lost all strength.  I have very little control over my right index finger and no power to pick anything up or push with any kind of force.
100.6 degree fever; rash on chest and back; 2 vesicular lesions
Left deltoid: red area 80mm right to left, x 70 mm top to bottom. Warm to touch. Area soft.
Patient complains of slight fever, nausea, chills. fatigue, and shake the next day of vaccination.
This spontaneous report as received from a other health professional (licensed practical nurse) refers to a patient of unknown age. Medical history and current condition were not reported. On an unknown date, the patient was vaccinated with (Oka/Merck) VARIVAX, 0.5 milliliter, subcutaneous for unknown indication. Concomitant medications were not reported. It was reported that (Oka/Merck) VARIVAX was exposed to temperature warmer than -15 degrees Celsius (C) but no warmer than -8.5 degrees C on 17 different occasions for a total time of 17 hours out of range, have been administered. No adverse effect reported. No product quality complaint reported. This case is linked to 1410USA005550 (same reporter). Additional information has been requested.
The patient received Hepatitis B injection on 10/20/00 around 10:30 AM, around 1 PM she developed hives "from head to toe", warmth, and flushing. The patient took antihistamines, all symptoms resolved within 24 hours.
This spontaneous report as received from a nurse practitioner refers to a 17 year old patient of unknown gender. On 15-DEC-2014, the patient was inadvertently vaccinated with a dose of (Merck) PROQUAD (dose, lot number, expiration date were not provided). No adverse effect was reported. Additional information has been requested.
Patient reports light headedness, mild dizziness and nausea. Vitals 98% and heart rate 79. Patient asked to lay down. Cold water offered. Observed  patient for 15 minutes. He became fine and was able to drive home.
I would like to report a pregnancy; This spontaneous prospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (I would like to report a pregnancy) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L2A) for COVID-19 vaccination.     The patient's past medical history included ADHD (No medications during pregnancy) in 2010 and Alcohol use (Ver rarely, during holidays or celebrations.). Previously administered products included for ADHD: Vyvanse. Concurrent medical conditions included Nickel sensitivity and Morning sickness (during current pregnancy).    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 08-Nov-2020 and the estimated date of delivery was 14-Aug-2021. On 13-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (I would like to report a pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  ninth week of the pregnancy.  On 13-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (I would like to report a pregnancy) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Jan-2021, Ultrasound scan: abnormal (abnormal) Chronic bump on ultrasound, estimated gestational age.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment was provided.; Sender's Comments: Based on the current available information and the temporal association between the product sue and the start date of the event a causal relationship cannot be excluded.
pt reports muscle pain and stiffness that extends down arm and up into left side of neck since vaccination
This spontaneous report as received from a consumer refers to her 16 years old son. The patient was vaccinated with dose 1 GARDASIL in April 2011. The patient had not yet received a 2nd dose. It was unknown if the patient had sought medical attention. Additional information is not expected.
Delayed reaction of what I discovered is referred to as "Moderna Arm" This morning, 11 days after my 1st dose, I noticed a smaller size rash on my left arm at the injection site and as the day has progressed the rash has gotten bigger, began to itch and has heat to the touch. I also feel feverish and feel as though there is a lump in my throat.
This is a spontaneous report received from a contactable healthcare professional. An elderly patient (reported as older than 65-year-old) of an unspecified ethnicity and gender received PREVNAR 13, via an unspecified route of administration on an unspecified date at single dose for immunization. The patient's medical history was and concomitant medications were not reported. On an unspecified date, it was reported that the patient has an arm that is sore with red circle 4 inches from the shot and is hot to touch. The outcome of the events was not recovered. Information regarding the batch number has been requested.
Patient presented to pharmacy 8 months after flu vaccination stating she had pain stemming from injection on 1/12/10. No hospitalization required, but followed up w/primary physician.
Monovalent Pfizer vaccine was given to patient instead of Bivalent. Patient is not experiencing any adverse effects from vaccine.